BDRX
Biodexa Pharmaceticals
NASDAQ: BDRX · HEALTHCARE · BIOTECHNOLOGY
$3.14
-3.09% today
Updated 2026-04-30
Market cap
$2.14M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-3.38
Dividend yield
—
52W range
$3 – $97
Volume
2.5M
Biodexa Pharmaceticals (BDRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $147000.00 | $157000.00 | $1.38M | $1.32M | $989000.00 | $1.94M | $674000.00 | $343000.00 | $578000.00 | $699000.00 | $381000.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | +6.8% | +775.8% | -3.8% | -25.2% | +96.0% | -65.2% | -49.1% | +68.5% | +20.9% | -45.5% | -100.0% | — |
| Cost of revenue | — | — | — | $70000.00 | $7.73M | $8.33M | $9.36M | $7.84M | $6.07M | $4.65M | $5.11M | $4.07M | $5.44M | $184857.00 |
| Gross profit | — | $147000.00 | $157000.00 | $1.30M | $-6.41M | $-7.34M | $-7.42M | $-7.17M | $-5.72M | $-4.08M | $-4.41M | $-3.69M | $-5.44M | $-184857.00 |
| Gross margin | — | 100.0% | 100.0% | 94.9% | -484.3% | -742.2% | -382.9% | -1063.6% | -1669.1% | -705.2% | -631.2% | -967.5% | — | — |
| R&D | $1.65M | $2.84M | $5.44M | $8.71M | $7.73M | $9.83M | $9.36M | $7.84M | $16.15M | $4.65M | $5.11M | $4.07M | $5.44M | $3.73M |
| SG&A | $2.36M | $1.81M | $4.23M | $2.08M | $3.25M | $4.27M | $4.39M | $3.84M | $4.96M | $2.95M | $4.54M | $4.34M | $3.79M | $4.84M |
| Operating income | $-4.01M | $-4.50M | $-7.71M | $-10.09M | $-9.65M | $-11.78M | $-11.81M | $-11.32M | $-23.04M | $-7.00M | $-8.93M | $-8.01M | $-9.20M | $-8.27M |
| Operating margin | — | -3060.5% | -4914.0% | -734.0% | -729.6% | -1190.7% | -609.6% | -1679.2% | -6717.2% | -1210.7% | -1277.8% | -2103.4% | — | — |
| EBITDA | $-3.81M | $-4.25M | $-9.36M | $-10.49M | $-5.30M | $-10.61M | $-10.70M | $-9.54M | $-22.22M | $-5.66M | $-8.26M | $-7.16M | $-9.08M | $-8.08M |
| EBITDA margin | — | -2893.2% | -5959.9% | -762.9% | -400.8% | -1072.7% | -552.3% | -1415.6% | -6477.8% | -979.1% | -1181.8% | -1879.5% | — | — |
| EBIT | $-4.01M | $-4.50M | $-9.68M | $-11.23M | $-9.65M | $-11.78M | $-11.81M | $-10.83M | $-23.44M | $-6.06M | $-8.44M | $-7.44M | $-9.20M | $-8.27M |
| Interest expense | — | $248000.00 | $161000.00 | — | — | $109000.00 | $587000.00 | $97000.00 | $34000.00 | $44000.00 | $53000.00 | $41000.00 | $165000.00 | $68465.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.99M | $-4.08M | $-8.82M | $-10.10M | $-6.16M | $-11.71M | $-10.37M | $-10.09M | $-22.19M | $-5.46M | $-7.66M | $-7.08M | $-5.73M | $-6.24M |
| Net income growth (YoY) | — | -2.3% | -116.0% | -14.5% | +39.0% | -90.0% | +11.4% | +2.7% | -120.0% | +75.4% | -40.2% | +7.5% | +19.1% | -9.0% |
| Profit margin | — | -2778.2% | -5619.1% | -734.5% | -465.7% | -1183.5% | -535.0% | -1496.3% | -6469.1% | -944.6% | -1095.3% | -1858.0% | — | — |